Ambaw Bellete

Ambaw serves as President & Chief Operating Officer at CG Oncology where he has responsibility for the overall commercial organization comprised of sales and marketing, communications and advocacy, business analytics and operations, health outcomes research, and patient access. In addition to leading our business development, corporate strategy, quality, regulatory affairs, and supply chain organization. Ambaw has over 30 years of experience in the biotech industry, and he has a proven track record of success building and leading multidisciplinary teams from pre-launch to commercialization. He is passionate about bringing new solutions to the bladder cancer community and maintaining a personal and compassionate focus on patients, their caregivers, and families. He previously served as CEO of Lion Healthcare Strategies, the Chief Operating Officer at FerGene, and was also President of Photocure, a company focused on photodynamic therapy to treat bladder cancer. He has also held several global leadership positions with biotech and medical device companies including as President of MCS. He started his biotech career at The Upjohn Company (now Pfizer) and then Sanofi, where he held diverse senior leadership roles. Ambaw currently serves as Chairman of the Board for OncoSTING and is a board member of Axiom Reach Foundation.